Available in 10 markets
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C is an exchange-traded fund (ETF) from Xtrackers, traded under the ticker XGES (ISIN IE000KD0BZ68). In a single purchase you get a diversified basket of holdings rather than a stake in just one business. At its core it is a focused, thematic fund: it concentrates on the health care part of the market,…
Opens the screener with this filter applied.
About this fund
What you own
The MSCI ACWI IMI Genomic Innovation Select Screened 100 Index index is the benchmark this fund aims to copy. By holding it, this fund gives you a stake in around 116 companies across Global in a single purchase.
Dividends
The fund automatically reinvests dividends back into itself, so your holding grows without cash payouts.
Read more
Rolling the dividends straight back in means your money compounds automatically, with nothing for you to reinvest by hand. The flip side is there is no cash income; the growth simply shows up as a higher fund value. Note that reinvested dividends can still be taxable in some countries even though you never receive the cash — the rules depend on where you live.
How it works
The fund actually buys every share in the index it tracks (full replication).
Read more
Owning every holding keeps things transparent — what is in the index is what the fund actually owns. It can be a touch costlier to run for indexes with thousands of tiny positions, since the fund has to buy and maintain them all. There is no swap bank involved, so there is no extra “what if the partner fails” question to weigh.
Cost
The yearly running cost of the fund, shown as a % of your money. Lower is cheaper.
Read more
For example, a 0.20% fee works out at €0.20 a year for every €100 invested — that’s a generic illustration of the mechanic, not this fund’s own fee. It is skimmed quietly from inside the fund a little each day, so you never get a bill — but it drags on your return every year you hold. On a broad index ETF it is usually a small fraction of a percent; the gap between a cheap and a pricey fund looks tiny on day one but compounds over decades, which is why it is worth a glance.
Fund facts
Performance
The bigger picture
What's inside
By sector ?
The 10 biggest holdings make up 43.8% of the fund — the rest is spread across roughly 106 more companies.
Top 10 holdings
| # | Company | Weight |
|---|---|---|
| 1 | ILLUMINA INC | 4.8% |
| 2 | VERTEX PHARMACEUTICALS | 4.6% |
| 3 | NATERA | 4.6% |
| 4 | LONZA GROUP AG | 4.5% |
| 5 | DANAHER | 4.5% |
| 6 | AGILENT TECHNOLOGIES INC | 4.5% |
| 7 | GSK AMERICAN DEPOSITORY SHARES REP | 4.4% |
| 8 | ROCHE PS PAR AG | 4.1% |
| 9 | ARGENX SE ADR | 4.0% |
| 10 | MODERNA | 4.0% |
Where to buy this fund
Set from your language & location — change it if it's wrong.
Where it trades
| Exchange | Ticker | Currency | |
|---|---|---|---|
| LSE | XGES | USD | ★ Primary |
| CHF listings | |||
| SIX | XGEN | CHF | |
| EUR listings | |||
| Borsa Italiana | XGEN | EUR | |
| Frankfurt | XGEN | EUR | |
| USD listings | |||
| E1 | XGENEUR | USD | |
| E1 | XGENGBP | USD | |
| E1 | XGENUSD | USD | |
| E1 | XGENCHF | USD | |
| EP | XGENCHF | USD | |
| EP | XGENEUR | USD | |
| EU | XGENUSD | USD | |
| EU | XGENGBP | USD | |
| EU | XGENEUR | USD | |
| EU | XGENCHF | USD | |
| EZ | XGENCHF | USD | |
| EZ | XGENEUR | USD | |
| GD | XGEN | USD | |
| GH | XGEN | USD | |
| GM | XGEN | USD | |
| GS | XGEN | USD | |
| GT | XGEN | USD | |
| GZ | XGEN | USD | |
| LA | XGEN | USD | |
| LSE | XGEN | USD | |
| LU | XGEN | USD | |
| MF | XGENN | USD | |
| MM | XGENN | USD | |
| MU | XGENN | USD | |
| QT | XGEN | USD | |
| SE | XGEN | USD | |
| TH | XGEN | USD | |
| X1 | XGENCHF | USD | |
| X1 | XGENEUR | USD | |
| X1 | XGENGBP | USD | |
| X1 | XGENUSD | USD | |
| X2 | XGENUSD | USD | |
| X2 | XGENGBP | USD | |
| X2 | XGENEUR | USD | |
| X2 | XGENCHF | USD | |
| X9 | XGENEUR | USD | |
| XA | XGENUSD | USD | |
| XA | XGENGBP | USD | |
| XA | XGENEUR | USD | |
| XA | XGENCHF | USD | |
| XE | XGENCHF | USD | |
| XE | XGENEUR | USD | |
| XE | XGENGBP | USD | |
| XE | XGENUSD | USD | |
| XF | XGENUSD | USD | |
| XF | XGENGBP | USD | |
| XF | XGENEUR | USD | |
| XF | XGENCHF | USD | |
| XG | XGENUSD | USD | |
| XG | XGENGBP | USD | |
| XG | XGENEUR | USD | |
| XG | XGENCHF | USD | |
| XH | XGENCHF | USD | |
| XH | XGENEUR | USD | |
| XH | XGENGBP | USD | |
| XH | XGENUSD | USD | |
| XJ | XGENUSD | USD | |
| XJ | XGENGBP | USD | |
| XJ | XGENEUR | USD | |
| XJ | XGENCHF | USD | |
| XL | XGENUSD | USD | |
| XL | XGENGBP | USD | |
| XL | XGENEUR | USD | |
| XL | XGENCHF | USD | |
| XO | XGENCHF | USD | |
| XO | XGENEUR | USD | |
| XO | XGENGBP | USD | |
| XO | XGENUSD | USD | |
| XQ | XGENUSD | USD | |
| XQ | XGENGBP | USD | |
| XQ | XGENEUR | USD | |
| XQ | XGENCHF | USD | |
| XS | XGENUSD | USD | |
| XS | XGENGBP | USD | |
| XS | XGENEUR | USD | |
| XS | XGENCHF | USD | |
| XT | XGENCHF | USD | |
| XU | XGENUSD | USD | |
| XU | XGENGBP | USD | |
| XU | XGENEUR | USD | |
| XU | XGENCHF | USD | |
| XV | XGENCHF | USD | |
| XV | XGENEUR | USD | |
| XV | XGENGBP | USD | |
| XV | XGENUSD | USD | |
| XW | XGENUSD | USD | |
| XW | XGENGBP | USD | |
| XW | XGENEUR | USD | |
| XW | XGENCHF | USD | |
| XX | XGENCHF | USD | |
| XX | XGENEUR | USD | |
| XX | XGENGBP | USD | |
| XX | XGENUSD | USD | |
| XY | XGENUSD | USD | |
| XY | XGENGBP | USD | |
| XY | XGENEUR | USD | |
| XY | XGENCHF | USD | |
| XZ | XGENCHF | USD | |
| XZ | XGENEUR | USD | |
| XZ | XGENGBP | USD | |
| XZ | XGENUSD | USD | |
For serious comparison — full data holdings, percentiles, advanced risk, tilt, flows
Full holdings
As of 2026-09-24 · the fund's own published holdings.
| # | Company | Weight |
|---|---|---|
| 1 | ILLUMINA INC | 4.8% |
| 2 | VERTEX PHARMACEUTICALS | 4.6% |
| 3 | NATERA | 4.6% |
| 4 | LONZA GROUP AG | 4.5% |
| 5 | DANAHER | 4.5% |
| 6 | AGILENT TECHNOLOGIES INC | 4.5% |
| 7 | GSK AMERICAN DEPOSITORY SHARES REP | 4.4% |
| 8 | ROCHE PS PAR AG | 4.1% |
| 9 | ARGENX SE ADR | 4.0% |
| 10 | MODERNA | 4.0% |
| 11 | INSMED | 3.7% |
| 12 | GUARDANT HEALTH | 3.7% |
| 13 | WUXI BIOLOGICS CAYMAN | 3.3% |
| 14 | MEDPACE HOLDINGS | 2.5% |
| 15 | REVVITY | 2.4% |
| 16 | INNOVENT BIOLOGICS | 2.0% |
| 17 | SANDOZ GROUP AG | 1.8% |
| 18 | QUEST DIAGNOSTICS INC | 1.7% |
| 19 | QIAGEN | 1.7% |
| 20 | BIO TECHNE | 1.6% |
| 21 | BEONE MEDICINES AG | 1.6% |
| 22 | MADRIGAL PHARMACEUTICALS | 1.5% |
| 23 | KRYSTAL BIOTECH | 1.4% |
| 24 | TWIST BIOSCIENCE | 1.4% |
| 25 | EXELIXIS INC | 1.3% |
| 26 | ARROWHEAD PHARMACEUTICALS | 1.2% |
| 27 | TEMPUS AI CLASS A | 1.1% |
| 28 | ROIVANT SCIENCES LTD | 1.0% |
| 29 | BRIDGEBIO PHARMA | 1.0% |
| 30 | GENSCRIPT BIOTECH CORP | 0.9% |
| 31 | CRISPR THERAPEUTICS AG | 0.9% |
| 32 | 10X GENOMICS CLASS A | 0.9% |
| 33 | BIOMARIN PHARMACEUTICAL | 0.9% |
| 34 | COGENT BIOSCIENCES | 0.7% |
| 35 | BRUKER | 0.7% |
| 36 | VERACYTE | 0.7% |
| 37 | PRAXIS PRECISION MEDICINES | 0.6% |
| 38 | CYTOKINETICS | 0.6% |
| 39 | ORUKA THERAPEUTICS INC | 0.5% |
| 40 | VAXCYTE | 0.5% |
| 41 | BEAM THERAPEUTICS | 0.5% |
| 42 | JIANGSU HENGRUI MEDICINE LTD A | 0.5% |
| 43 | VIKING THERAPEUTICS | 0.4% |
| 44 | IDEAYA BIOSCIENCES | 0.4% |
| 45 | KINIKSA PHARMACEUTICALS INTERNATIO | 0.4% |
| 46 | BIO RAD LABORATORIES CLASS A | 0.3% |
| 47 | DYNE THERAPEUTICS | 0.3% |
| 48 | GRIFOLS CLASS A | 0.3% |
| 49 | INTELLIA THERAPEUTICS | 0.3% |
| 50 | LEGEND BIOTECH ADR REP | 0.3% |
| 51 | NEWAMSTERDAM PHARMA | 0.3% |
| 52 | SAREPTA THERAPEUTICS | 0.3% |
| 53 | TANGO THERAPEUTICS | 0.3% |
| 54 | BIOARCTIC CLASS B | 0.3% |
| 55 | DIANTHUS THERAPEUTICS INC | 0.3% |
| 56 | ENLIVEN THERAPEUTICS | 0.3% |
| 57 | RELAY THERAPEUTICS | 0.3% |
| 58 | MESOBLAST ADR REPRESENTING | 0.3% |
| 59 | ARCUS BIOSCIENCES | 0.3% |
| 60 | ADAPTIVE BIOTECHNOLOGIES | 0.3% |
| 61 | AMYLYX PHARMACEUTICALS | 0.2% |
| 62 | MBX BIOSCIENCES | 0.2% |
| 63 | SCHOLAR ROCK HOLDING | 0.2% |
| 64 | SHENZHEN MINDRAY BIO-MEDICAL ELECT | 0.2% |
| 65 | NEKTAR THERAPEUTICS | 0.2% |
| 66 | IMMUNOVANT | 0.2% |
| 67 | UNIQURE | 0.2% |
| 68 | VIRIDIAN THERAPEUTICS ORS INC | 0.2% |
| 69 | OXFORD NANOPORE TECHNOLOGIES PLC | 0.2% |
| 70 | KYOWA KIRIN LTD | 0.2% |
| 71 | CELLDEX THERAPEUTICS | 0.2% |
| 72 | HINGE HEALTH CLASS A | 0.2% |
| 73 | ROCHE HOLDING AG | 0.2% |
| 74 | TREVI THERAPEUTICS | 0.2% |
| 75 | INHIBRX BIOSCIENCES INC | 0.2% |
| 76 | ULTRAGENYX PHARMACEUTICAL | 0.2% |
| 77 | ACADIA PHARMACEUTICALS | 0.2% |
| 78 | TAYSHA GENE THERAPIES | 0.2% |
| 79 | NURIX THERAPEUTICS INC | 0.1% |
| 80 | PALVELLA THERAPEUTICS INC | 0.1% |
| 81 | BIOHAVEN | 0.1% |
| 82 | CELCUITY | 0.1% |
| 83 | VERICEL | 0.1% |
| 84 | DIASORIN | 0.1% |
| 85 | FORTREA HOLDINGS INC | 0.1% |
| 86 | SYNDAX PHARMACEUTICALS | 0.1% |
| 87 | RECURSION PHARMACEUTICALS CLASS A | 0.1% |
| 88 | CORVEL | 0.1% |
| 89 | PHARMARON BEIJING LTD A | 0.1% |
| 90 | DISC MEDICINE | 0.1% |
| 91 | PHARMA MAR SA | 0.1% |
| 92 | SWISS FRANC | 0.1% |
| 93 | TYRA BIOSCIENCES | 0.1% |
| 94 | STOKE THERAPEUTICS | 0.1% |
| 95 | OLIX PHARMACEUTICALS INC | 0.1% |
| 96 | CARSGEN THERAPEUTICS LTD | 0.1% |
| 97 | US DOLLAR | 0.1% |
| 98 | ALUMIS | 0.1% |
| 99 | SHENZHEN NEW INDUSTRIES BIOMEDICAL | 0.0% |
| 100 | CAPRICOR THERAPEUTICS | 0.0% |
| 101 | HANGZHOU TIGERMED CONSULTING LTD A | 0.0% |
| 102 | HONG KONG DOLLAR | 0.0% |
| 103 | JAPANESE YEN | 0.0% |
| 104 | YUAN RENMINBI | 0.0% |
| 105 | EURO CURRENCY | 0.0% |
| 106 | SWEDISH KRONA | 0.0% |
| 107 | NEW TAIWAN DOLLAR | 0.0% |
| 108 | POUND STERLING | 0.0% |
| 109 | AUSTRALIAN DOLLAR | 0.0% |
| 110 | SOUTH KOREAN WON | 0.0% |
| 111 | CANADIAN DOLLAR | 0.0% |
| 112 | DANISH KRONE | 0.0% |
| 113 | CONTRA ARCELLX INC | 0.0% |
| 114 | - | 0.0% |
| 115 | CONTRA MIRATI THERAPEU | 0.0% |
| 116 | CONTRA CHINOOK THERAPE | 0.0% |
How it ranks vs peers
Versus the Equity (stocks) · Global · EUR ETFs we track.
Advanced risk
Concentration depth
Roughly 116 companies are held, but the largest names carry most of the weight — so it behaves like ~35 equal-sized positions.
Tilt vs a world tracker
Percentage points over / under a broad world-equity tracker (not a licensed benchmark).
Documents
Similar funds
We found 6 funds that do much the same job as this one. To pick them we matched this fund's asset class and region, then show how close each match is below.
| Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1CXtrackersYou're viewing | iShares Core MSCI World UCITS ETFiSharesBroader match | iShares Core MSCI World UCITS ETFiSharesBroader match | iShares Core MSCI World UCITS ETFiSharesBroader match | iShares Core MSCI World UCITS ETFiSharesBroader match | State Street® SPDR® Portfolio Developed World ex-US ETFSPDRBroader match | iShares MSCI ACWI UCITS ETFiSharesBroader match | |
|---|---|---|---|---|---|---|---|
| Why it's similar | This is the fund on this page. | StocksPhysical Tracks a different index in the same category. | StocksPhysical Tracks a different index in the same category. | StocksPhysicalCheaper fee Tracks a different index in the same category. | StocksAccumulatingPhysicalCheaper fee Tracks a different index in the same category. | StocksPhysicalCheaper fee Tracks a different index in the same category. | StocksAccumulatingPhysicalCheaper fee Tracks a different index in the same category. |
| Index tracked | MSCI ACWI IMI Genomic Innovation Select Screened 100 Index | MSCI World | MSCI World | MSCI World | MSCI World | S&P Developed Ex-U.S. BMI Index | MSCI ACWI |
| Yearly fee (TER) | 0.30% | 0.30% | 0.30% | 0.20% | 0.20% | 0.03% | 0.20% |
| All-in cost | 0.30% | 0.30% | 0.00% | 0.00% | 0.20% | 0.00% | 0.20% |
| Fund size | €0 | €170.9B | €146.5B | €128.1B | €127.6B | €36.5B | €30.9B |
| Domicile | Ireland | Ireland | Ireland | Ireland | Ireland | United States | Ireland |
| Replication | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) |
| 3-yr return p.a. | +16.8% | +17.8% | +18.3% | +17.2% | +17.9% | ||
| 5-yr return p.a. | +9.7% | +9.3% | +11.3% | +6.3% | +10.4% | ||
| # holdings | 116 | 1,356 | 1,356 | 1,356 | 1,356 | 2,459 | 1,738 |
The fund on this page stays pinned on the left — scroll or use ‹ › to compare it against each one.
Open the full comparison tool →New to ETFs? Start with the basics →
Finance Hamster provides educational information about ETFs and investing. It is not investment, tax, or legal advice, and not a recommendation to buy or sell any security. Markets carry risk; do your own research or consult a licensed adviser.